机译:SHMT2驱动缺血性脑胶质瘤细胞的存活,但对甘氨酸清除率有依赖性
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
Human Metabolome Technologies, Inc., Tsuruoka 997-0052, Japan;
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA,Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA;
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
Human Metabolome Technologies America, Inc., Boston, Massachusetts 02134, USA;
The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA;
Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA,Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA,Department of Pathology, Boston Children's Hospital, Boston, Massachusetts 02115, USA;
Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA,Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA,Department of Pathology, Boston Children's Hospital, Boston, Massachusetts 02115, USA;
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
Department of Pathology, NYU Langone Medical Center and Medical School, New York, New York 10016, USA;
The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA,Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA;
Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, Massachusetts 02142, USA,Howard Hughes Medical Institute and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA,The David H. Koch Institute for Integrative Cancer Research at MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA,Department of Biology, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA,Broad Institute of Harvard and MIT, Seven Cambridge Center, Cambridge, Massachusetts 02142, USA;
机译:SHMT2 SIRT5通过SIRT5驱动癌细胞增殖
机译:脑胶质瘤生存和细胞迁移对CD44表达水平的双相依赖性。
机译:MAP-ing神经胶质瘤侵袭:丝裂原激活的蛋白激酶激酶3和p38驱动神经胶质瘤侵袭和进展并预测患者存活率。
机译:烟酰胺在光动力学治疗后增强了胶质瘤细胞的存活和凋亡率
机译:NRG-1激活ErbB受体可增强人类星形胶质瘤细胞的存活和迁移。
机译:SHMT2在肿瘤微环境中驱动神经胶质瘤细胞存活但对甘氨酸清除率有依赖性
机译:sHmT2在缺血时驱动神经胶质瘤细胞存活,但对甘氨酸清除有依赖性